Seres Therapeutics Inc Price Chart
Seres Therapeutics Inc 1S9.BE Financial and Trading Overview
| Seres Therapeutics Inc stock price | 0.81 EUR |
| Previous Close | 5.6 EUR |
| Open | 5.2 EUR |
| Bid | 5.2 EUR x 0 |
| Ask | 5.3 EUR x 0 |
| Day's Range | 5.2 - 5.2 EUR |
| 52 Week Range | 2.58 - 9.4 EUR |
| Volume | 100 EUR |
| Avg. Volume | 169 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
1S9.BE Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Seres Therapeutics Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 9.4 EUR |
| 52 Week Low | 2.58 EUR |
| 50-Day Moving Average | 4.95 EUR |
| 200-Day Moving Average | 5.58 EUR |
1S9.BE Share Statistics
| Avg. Volume (3 month) | 169 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Seres Therapeutics Inc Stock
What is a current 1S9.BE stock price?
Seres Therapeutics Inc 1S9.BE stock price today per share is 0.81 EUR.
How to purchase Seres Therapeutics Inc stock?
You can buy 1S9.BE shares on the Berlin exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Seres Therapeutics Inc?
The stock symbol or ticker of Seres Therapeutics Inc is 1S9.BE.
How many shares does Seres Therapeutics Inc have in circulation?
The max supply of Seres Therapeutics Inc shares is 0.
What is Seres Therapeutics Inc Price to Earnings Ratio (PE Ratio)?
Seres Therapeutics Inc PE Ratio is now.
What was Seres Therapeutics Inc earnings per share over the trailing 12 months (TTM)?
Seres Therapeutics Inc EPS is 0 EUR over the trailing 12 months.